By using, you agree to our terms and use of cookies to enhance your experience.

Global diabetes child care programme extended

By Editor
1st December 2016
Education, Latest news Paediatrics

A programme which provides children wth type 1 diabetes around the world free access to insulin and treatment has been extended.

The Changing Diabetes® in Children initiative will continue for another four years and it has been estimated that 20,000 children will have been helped by 2020.

The expansion has also seen five new countries join the programme which include Cambodia, Ivory Coast, Myanmar, Senegal and Sudan.

The project was launched because a decade ago a child’s life expectancy in Sub-Saharan Africa diagnosed with type 1 diabetes was often less than a year.

Novo Nordisk launched the programme to support sustainable quality care and improved diagnosis of the condition.

Since the start of the programme in 2009, 13,700 children in nine countries in Africa and South-East Asia have received free human insulin and access to diabetes care.

Professor Azad Khan, president of the Diabetic Association of Bangladesh, said: “The Changing Diabetes® in Children programme has been iconic.

“It has changed the lives of children with type 1 diabetes in Bangladesh. Their survival depends on the supply of insulin as well as education on how to cope with diabetes, and the programme provides all of this.”

A large number of children enrolled in the programme are now in good control and are able to lead healthy lives.

To date, 108 clinics have been established and more than 7,000 healthcare professionals have been trained in diabetes care.

In addition to providing access to insulin, the Changing Diabetes® in Children programme aims to support the development of sustainable healthcare systems.

Lars Rebien Sørensen, president and CEO of Novo Nordisk, said: “The provision of free medicine alone doesn’t solve complex healthcare challenges.

“From the outset of this programme, we have therefore worked closely with local partners to deliver sustainable solutions alongside insulin to improve the lives of children with type 1 diabetes both now and in the future.”

Comments (0)

Register an account or login to comment